tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Is ARWR a Buy, Before Earnings?
PremiumPre-EarningsIs ARWR a Buy, Before Earnings?
14d ago
Arrowhead doses first patient in ARO-DIMER-PA trial
Premium
The Fly
Arrowhead doses first patient in ARO-DIMER-PA trial
21d ago
Arrowhead price target raised to $101 from $61 at B. Riley
Premium
The Fly
Arrowhead price target raised to $101 from $61 at B. Riley
26d ago
Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
PremiumCompany AnnouncementsArrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
1M ago
Arrowhead 3.1M share Secondary priced at $64.50
Premium
The Fly
Arrowhead 3.1M share Secondary priced at $64.50
1M ago
Arrowhead announces China NMPA approval for Redemplo
Premium
The Fly
Arrowhead announces China NMPA approval for Redemplo
1M ago
Arrowhead Reports Promising Interim Data for Obesity RNAi Trials
PremiumCompany AnnouncementsArrowhead Reports Promising Interim Data for Obesity RNAi Trials
1M ago
Clear Street keeps Buy on Wave Life Sciences after Arrowhead data
Premium
The Fly
Clear Street keeps Buy on Wave Life Sciences after Arrowhead data
1M ago
H.C. Wainwright says initial Phase 1/2a data de-risk Arrowhead obesity franchise
Premium
The Fly
H.C. Wainwright says initial Phase 1/2a data de-risk Arrowhead obesity franchise
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100